Putting Risk into Proper Perspective

A few years ago when my wife and I bought our home, we found ...

Just Plain Smart HCP Communications

As we all know, much has been written about the benefits of multi-channel communications. ...

Is There a Doctor In-House?

A combination of conflict of interest concerns, public disclosure via the Sunshine Act and—particularly ...

PM360 Q&A with John Theobald, CEO, Healthcasts

John Theobald could be said to be a maverick. Starting with his first entrepreneurial ...

Ineffective Drug Versus Poor Adherence

In the world of dermatology, topical corticosteroids are the most widely used treatments. They ...

Speaker Programs: RIP

On Tuesday, December 17th, 2013, GlaxoSmithKline, the sixth-largest global drug maker, announced that it ...

Risk of Sudden Changes in Adherence

Taking a new medication can change the levels of other medicines—sometimes dangerously. Methotrexate is ...

One Physician’s View on Drug Co-pay Cards

Discounts are a staple of the American culture. The Sunday section of almost every ...

What Do Weight Watchers and the Grameen Bank Have In Common?

In 1983, Muhammad Yunus founded the Grameen Bank to provide credit and banking services ...

Doctors’ View Into the Future of Medicine: What Can Pharma Learn?

A Survey of America’s Physicians: Practice Patterns and Perspectives was recently completed on behalf ...

Fear of Side Effects

Fear of side effects is a major contributor to patients’ poor adherence. Some patients ...

What the Industry Should Take Away from the Avandia Fiasco

GlaxoSmithKline’s Avandia (rosiglitazone) is an excellent drug. It is the only oral diabetes medication ...